telesta therapeutics inc (TST:Toronto)
Michael J. Berendt Ph.D.
Chief Executive Officer, Chief Scientist and Director,Telesta Therapeutics Inc.
|Age||Total Calculated Compensation||This person is connected to 42 board members in 7 different organizations across 14 different industries.|
See Board Relationships
As of Fiscal Year 2014
Dr. Michael J. Berendt, Ph.D., has been the Chief Executive Officer at Bioniche Life Sciences Inc. since November 4, 2013 and has been its Chief Scientist Officer since November 2013. Dr. Berendt served as the Chief Executive Officer and President of Aegera Therapeutics, Inc., since January 14, 2007 until 2011. Dr. Berendt served as the Managing Director of AEA Investors LP. He served as a Consultant of Bioniche Life Sciences Inc. From November 2000 to August 2004, he ...
231 Dundas Street EastPhone: 613-966-8058
Belleville, Ontario K8N 1E2
Board Members Memberships*
Interim Chairman and Chairman of Compensation Committee
Independent Director and Chairman of Nominating & Corporate Governance Committee
Director and Chairman of Nominating & Corporate Governance Committee
Chief Executive Officer, Chief Scientist and Director
Ohio Dominican College
Hahnemann University Medical School
|There is no Competitor Compensation data available.|